Skip to main content
Premium Trial:

Request an Annual Quote

Too Trying to Get Reimbursements

Howard Jacob is leaving the HudsonAlpha Institute for Biotechnology after three years there, reports. He was the executive vice president for genomic medicine and chief medical genomics officer there.

Jacob came to HudsonAlpha in 2015 from the Medical College of Wisconsin. Shortly after his arrival, the institute opened a center for clinical whole-genome sequencing, called the Smith Family Clinic for Genomic Medicine, with the aim of being able to diagnose patients with rare diseases. In 2015, Jacob said the cost of sequencing and analyzing patients' genomes would be around $6,000 and likely not covered by health insurance companies.

That, says, has been a sticking point for Jacob. He tells the news site that Blue Cross Blue Shield of Alabama, the most prominent insurer in the state, wouldn't pay for such testing. "The hard part is that reimbursement for genomics is just not there," Jacob says. "I think everybody was hoping we'd be able to move this faster on the clinical side."

Rick Myers, the president and science director of HudsonAlpha, says in a statement that the institute has been able to show that genomic medicine can "[provide] answers to hundreds of families in Alabama" and that it will work with Blue Cross Blue Shield of Alabama and other Alabama healthcare organizations 

Jacob has joined AbbVie as vice president of genomic research.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.